These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 10417130)
1. Identification of functional domains of Bordetella dermonecrotizing toxin. Kashimoto T; Katahira J; Cornejo WR; Masuda M; Fukuoh A; Matsuzawa T; Ohnishi T; Horiguchi Y Infect Immun; 1999 Aug; 67(8):3727-32. PubMed ID: 10417130 [TBL] [Abstract][Full Text] [Related]
2. Identification of a receptor-binding domain of Bordetella dermonecrotic toxin. Matsuzawa T; Kashimoto T; Katahira J; Horiguchi Y Infect Immun; 2002 Jul; 70(7):3427-32. PubMed ID: 12065482 [TBL] [Abstract][Full Text] [Related]
3. Escherichia coli cytotoxic necrotizing factors and Bordetella dermonecrotic toxin: the dermonecrosis-inducing toxins activating Rho small GTPases. Horiguchi Y Toxicon; 2001 Nov; 39(11):1619-27. PubMed ID: 11595625 [TBL] [Abstract][Full Text] [Related]
4. Molecular localization of the Escherichia coli cytotoxic necrotizing factor CNF1 cell-binding and catalytic domains. Lemichez E; Flatau G; Bruzzone M; Boquet P; Gauthier M Mol Microbiol; 1997 Jun; 24(5):1061-70. PubMed ID: 9220012 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the dermonecrotic toxin in members of the genus Bordetella. Walker KE; Weiss AA Infect Immun; 1994 Sep; 62(9):3817-28. PubMed ID: 8063398 [TBL] [Abstract][Full Text] [Related]
6. Bordetella bronchiseptica dermonecrotizing toxin stimulates assembly of actin stress fibers and focal adhesions by modifying the small GTP-binding protein rho. Horiguchi Y; Senda T; Sugimoto N; Katahira J; Matsuda M J Cell Sci; 1995 Oct; 108 ( Pt 10)():3243-51. PubMed ID: 7593285 [TBL] [Abstract][Full Text] [Related]
7. Bordetella bronchiseptica dermonecrotizing toxin, which activates a small GTP-binding protein rho, induces membrane organelle proliferation and caveolae formation. Senda T; Horiguchi Y; Umemoto M; Sugimoto N; Matsuda M Exp Cell Res; 1997 Jan; 230(1):163-8. PubMed ID: 9013718 [TBL] [Abstract][Full Text] [Related]
8. Pasteurella multocida toxin and Bordetella bronchiseptica dermonecrotizing toxin elicit similar effects on cultured cells by different mechanisms. Ohnishi T; Horiguchi Y; Masuda M; Sugimoto N; Matsuda M J Vet Med Sci; 1998 Mar; 60(3):301-5. PubMed ID: 9560776 [TBL] [Abstract][Full Text] [Related]
9. A single amino acid substitution in the enzymatic domain of cytotoxic necrotizing factor type 1 of Escherichia coli alters the tissue culture phenotype to that of the dermonecrotic toxin of Bordetella spp. McNichol BA; Rasmussen SB; Meysick KC; O'Brien AD Mol Microbiol; 2006 May; 60(4):939-50. PubMed ID: 16677305 [TBL] [Abstract][Full Text] [Related]
10. Activation of rho through a cross-link with polyamines catalyzed by Bordetella dermonecrotizing toxin. Masuda M; Betancourt L; Matsuzawa T; Kashimoto T; Takao T; Shimonishi Y; Horiguchi Y EMBO J; 2000 Feb; 19(4):521-30. PubMed ID: 10675321 [TBL] [Abstract][Full Text] [Related]
11. Bordetella dermonecrotic toxin undergoes proteolytic processing to be translocated from a dynamin-related endosome into the cytoplasm in an acidification-independent manner. Matsuzawa T; Fukui A; Kashimoto T; Nagao K; Oka K; Miyake M; Horiguchi Y J Biol Chem; 2004 Jan; 279(4):2866-72. PubMed ID: 14597616 [TBL] [Abstract][Full Text] [Related]
13. Identification of the C-terminal part of Bordetella dermonecrotic toxin as a transglutaminase for rho GTPases. Schmidt G; Goehring UM; Schirmer J; Lerm M; Aktories K J Biol Chem; 1999 Nov; 274(45):31875-81. PubMed ID: 10542213 [TBL] [Abstract][Full Text] [Related]
15. Cloning, expression, and molecular characterization of the dermonecrotic toxin gene of Bordetella spp. Pullinger GD; Adams TE; Mullan PB; Garrod TI; Lax AJ Infect Immun; 1996 Oct; 64(10):4163-71. PubMed ID: 8926084 [TBL] [Abstract][Full Text] [Related]
16. Properties of dermonecrotic toxin prepared from sonic extracts Bordetella bronchiseptica. Kume K; Nakai T; Samejima Y; Sugimoto C Infect Immun; 1986 May; 52(2):370-7. PubMed ID: 3699886 [TBL] [Abstract][Full Text] [Related]
17. Structure of the Rho-activating domain of Escherichia coli cytotoxic necrotizing factor 1. Buetow L; Flatau G; Chiu K; Boquet P; Ghosh P Nat Struct Biol; 2001 Jul; 8(7):584-8. PubMed ID: 11427886 [TBL] [Abstract][Full Text] [Related]
18. Production of Highly Active Recombinant Dermonecrotic Toxin of Stanek O; Linhartova I; Holubova J; Bumba L; Gardian Z; Malandra A; Bockova B; Teruya S; Horiguchi Y; Osicka R; Sebo P Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32942577 [TBL] [Abstract][Full Text] [Related]
19. Bordetella bronchiseptica dermonecrotizing toxin suppresses in vivo antibody responses in mice. Horiguchi Y; Matsuda H; Koyama H; Nakai T; Kume K FEMS Microbiol Lett; 1992 Jan; 69(3):229-34. PubMed ID: 1555757 [TBL] [Abstract][Full Text] [Related]
20. Immunological and protective effects of Bordetella bronchiseptica subunit vaccines based on the recombinant N-terminal domain of dermonecrotic toxin. Wang C; Liu L; Zhang Z; Yan Z; Yu C; Shao M; Jiang X; Chi S; Wei K; Zhu R Int Immunopharmacol; 2015 Oct; 28(2):952-9. PubMed ID: 26337750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]